Open Access

Obesity and CV disease – Lowering CV risk with novel weight loss strategies

Event: ESC Congress 2022
Topic: Obesity and Diabetes
Session type: Satellite Symposium
Sponsored by Medscape Education Global
Date: 26 August 2022
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

Why do cardiologists need to manage obesity?

Speaker: Professor J. Deanfield (London, GB)
Thumbnail

From pathophysiology to obesity management.

Speaker: Professor L. Van Gaal (Edegem-Antwerp, BE)
Thumbnail

Novel anti-obesity drugs in weight management.

Speaker: Professor H. Colhoun (Edinburgh, GB)
Thumbnail

Cases of multi-disciplinary obesity care in clinical practice.

Speaker: Professor L. Van Gaal (Edegem-Antwerp, BE)
Thumbnail

Weight loss trials on CVD benefit.

Thumbnail

Take home messages for cardiovascular practitioners.

Speaker: Professor J. Deanfield (London, GB)
Thumbnail

5 speakers from this session

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
40 presentations
2 followers

Professor Luc Van Gaal

, Edegem-Antwerp (Belgium)
2 presentations
0 follower

Professor Helen Colhoun

, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Professor Luc Van Gaal

, Edegem-Antwerp (Belgium)
2 presentations
0 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
40 presentations
2 followers

This platform is supported by

logo Novo Nordisk